STOCK TITAN

AptarGroup, Inc. - ATR STOCK NEWS

Welcome to our dedicated page for AptarGroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on AptarGroup stock.

AptarGroup, Inc. (ATR) is a global leader in providing a broad range of innovative dispensing systems for various markets, including beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage. Headquartered in Crystal Lake, Illinois, AptarGroup leverages its extensive manufacturing facilities across North America, Europe, Asia, and South America to serve customers worldwide.

Aptar's product portfolio includes aerosol valves, pumps, closures, and elastomer packaging components. The company operates through three primary business segments: Pharma, Beauty, and Closures. The Pharma division, which is the most significant contributor, is responsible for over two-thirds of the group's profits. The Beauty and Closures segments also play crucial roles in the company’s overall market strategy and revenue generation.

With the majority of its annual net sales stemming from Europe (50%) and the United States (33%), AptarGroup has been focusing on expanding its market presence in Asia (10%) and Latin America (7%). The company continually invests in research and development to maintain its competitive edge and deliver cutting-edge solutions to its clients.

Recent achievements for AptarGroup include strategic partnerships and product innovations that align with their commitment to sustainability and consumer satisfaction. The company continues to develop new dispensing technologies that are both eco-friendly and efficient, addressing the growing demand for sustainable packaging solutions.

For more detailed information about their products and services, visit their official website at www.aptar.com. Stay updated with AptarGroup’s latest developments and financial performance by following their news releases.

Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has been recognized in 3BL Media’s 100 Best Corporate Citizens ranking, highlighting its leadership and transparency in environmental, social, and governance (ESG) practices. The ranking evaluates major U.S. companies based on various ESG criteria. Aptar emphasizes its commitment to sustainability, aligning with United Nations Global Compact principles. President and CEO Stephan B. Tanda expressed pride in their corporate citizenship efforts, while Vice President Beth Holland noted ongoing commitments to stakeholder communication and global sustainability goals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
none
-
News
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) announced a 5% price increase for its beauty, personal care, and home care products, effective June 1, 2021. This decision responds to sustained cost inflation on non-raw material inputs, including freight, energy, and labor. Marc Prieur, President of Aptar Beauty + Home, emphasized the necessity of these adjustments due to unprecedented cost increases and efforts to ensure safe production amid the COVID-19 pandemic. Sales representatives will provide customers with more details on the price changes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
-
News
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) reported an 8% increase in first-quarter 2021 sales, totaling $777 million. Core sales rose 1%, driven by strong demand in the Food + Beverage segment. Reported earnings per share jumped 48% to $1.24, boosted by a non-cash gain of $0.19 per share from an equity investment. Adjusted earnings per share increased 10% to $1.09. The company expects second-quarter EPS guidance between $0.91 to $0.99, reflecting ongoing challenges in prescription drug markets but optimistic long-term growth potential. A quarterly dividend was increased by 6% to $0.38 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
News
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, representing a 6% increase from the previous dividend. The payment date is May 19, 2021, for stockholders of record as of April 28, 2021. In 2020, Aptar returned $93 million to shareholders and is set for its 28th consecutive year of increased annual dividends. The company achieved a Total Shareholder Return of 102% over the past five years, outperforming its peer group and the S&P Midcap 400.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
none
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter results with reported sales growing 12% to $749 million. Core sales increased 5%, driven by demand in Pharma and Food & Beverage segments. Earnings per share rose 8% to $0.79. For the year, reported sales grew 2% to $2.93 billion, but earnings per share fell 12% to $3.21 due to pandemic impacts. The company achieved record cash flow from operations of $570 million and declared a quarterly dividend of $0.36 per share, highlighting its commitment to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.21%
Tags
none
Rhea-AI Summary

AptarGroup (NYSE: ATR) announces a partnership with CARE® to support global health initiatives, including the Fast + Fair COVID-19 Vaccine Response Campaign. This initiative aims to ensure equitable vaccine access for over 100 million people, focusing on women, impoverished communities, and healthcare workers across 10 countries. Aptar’s sponsorship emphasizes its commitment to diversity, inclusion, and women's empowerment, while aligning with its business model of producing vaccine delivery components. The collaboration promises to enhance CARE's efforts in advocating for equitable health policies worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
covid-19
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has announced that its Activ-Film™ technology will protect a new SARS Rapid Antigen test for COVID-19, recently granted Emergency Use Authorization (EUA) by the FDA. This QuickVue® SARS Antigen test, developed by Quidel® Corporation, delivers results in just 10 minutes, enhancing access to affordable COVID-19 testing, especially in schools and rural areas. Activ-Film™ integrates material science to ensure test accuracy by protecting against moisture and environmental factors. Aptar is dedicated to providing critical healthcare solutions during the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
covid-19
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
dividends
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
conferences

FAQ

What is the current stock price of AptarGroup (ATR)?

The current stock price of AptarGroup (ATR) is $169.88 as of November 21, 2024.

What is the market cap of AptarGroup (ATR)?

The market cap of AptarGroup (ATR) is approximately 11.3B.

What products does AptarGroup manufacture?

AptarGroup manufactures aerosol valves, pumps, closures, and elastomer packaging components for various markets, including beauty, personal care, and pharmaceuticals.

Where is AptarGroup headquartered?

AptarGroup is headquartered in Crystal Lake, Illinois.

In which markets does AptarGroup operate?

AptarGroup operates in the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food, and beverage markets.

What are the main business segments of AptarGroup?

AptarGroup operates through three main business segments: Pharma, Beauty, and Closures.

Where does AptarGroup generate most of its sales?

AptarGroup generates most of its sales from Europe (50%) and the United States (33%).

What percentage of AptarGroup's profits come from the Pharma division?

The Pharma division generates over two-thirds of AptarGroup's profits.

Is AptarGroup expanding in any specific regions?

Yes, AptarGroup is focusing on increasing its presence in Asia (10%) and Latin America (7%).

How does AptarGroup contribute to sustainability?

AptarGroup invests in developing eco-friendly and efficient dispensing technologies to meet the increasing demand for sustainable packaging solutions.

How can I stay updated with AptarGroup's latest news?

You can stay updated with AptarGroup's latest news by following their news releases or visiting their official website at www.aptar.com.

AptarGroup, Inc.

NYSE:ATR

ATR Rankings

ATR Stock Data

11.26B
66.08M
0.56%
92.35%
0.68%
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States of America
CRYSTAL LAKE